Mireille Sanders
Chief Operating Officer at PHARMING GROUP N.V.
Net worth: 748 842 $ as of 2024-04-29
Mireille Sanders active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PHARMING GROUP N.V. | Chief Operating Officer | 2020-12-14 | - |
| Corporate Officer/Principal | 2019-04-30 | 2020-12-14 |
Career history of Mireille Sanders
Former positions of Mireille Sanders
| Companies | Position | Start | End |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 2015-12-31 | 2018-12-31 |
Training of Mireille Sanders
| Technische Universiteit Eindhoven | Graduate Degree |
Statistics
International
| Netherlands | 3 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Stock Market
- Insiders
- Mireille Sanders
- Experience